By InvitationNot Applicable

Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients

Turkey (Türkiye)100 participantsStarted 2024-09-01

Plain-language summary

Evaluation of sera of fibromyalgia patients in terms of energy metabolism function and possible alterations in metabolism predisposing to various degenerative/proliferative diseases.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: patients aged 18-65 years Patients with clinical complaints of fibromyalgia Exclusion Criteria: Viral or bacterial infections, Diabetes mellitus, Hypertension, Chronic renal failure, Hypo-hyperthyroidism) Patients taking antidepressants or medication, Smokers and alcohol users, Patients with rheumatic arthritis and systemic lupus erythematosus were excluded. \-

What they're measuring

Metabolomic Profiling

Timeframe: September 2024- February 2025

Trial details

NCT IDNCT06725199

Sponsorhatice kübra aşık

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-01

View on ClinicalTrials.gov More Patients with Clinical Complaints of Fibromyalgia Among the Patients Applying to the Outpatient Clinic trials